[P02BB01, trichlorfon, The therapeutic efficacy of Thiopental can be decreased when used in combination with Metrifonate.]
[G03XB02, ulipristal, The serum concentration of Ulipristal can be decreased when it is combined with Thiopental.]
[B01AD01, streptokinase, Thiopental may increase the hypotensive activities of Streptokinase.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Thiopental.]
[S01AB02, sulfisoxazole, The therapeutic efficacy of Thiopental can be increased when used in combination with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Thiopental.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Thiopental is combined with Sulthiame.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be decreased when it is combined with Thiopental.]
[N06DA01, tacrine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Thiopental.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Thiopental.]
[L01CB02, teniposide, The serum concentration of Teniposide can be decreased when it is combined with Thiopental.]
[R03CC03, terbutaline, The therapeutic efficacy of Thiopental can be decreased when used in combination with Terbutaline.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Thiopental.]
[N07XX06, tetrabenazine, The risk or severity of sedation and somnolence can be increased when Thiopental is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Thiopental is combined with Lurasidone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Thiopental.]
[N04BC07, apomorphine, Thiopental may increase the hypotensive activities of Apomorphine.]
[L04AX02, thalidomide, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The serum concentration of Theobromine can be decreased when it is combined with Thiopental.]
[R03DA04, theophylline, The serum concentration of Theophylline can be decreased when it is combined with Thiopental.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Thiopental.]
[L01AC01, thiotepa, The therapeutic efficacy of Thiopental can be decreased when used in combination with Thiotepa.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Thioproperazine is combined with Thiopental.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Thioridazine is combined with Thiopental.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Thiopental is combined with Thiothixene.]
[B02AB01, aprotinin, The therapeutic efficacy of Thiopental can be decreased when used in combination with Aprotinin.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Thiopental is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Thiopental can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Thiopental is combined with Tilidine.]
[S01ED01, timolol, Thiopental may increase the hypotensive activities of Timolol.]
[M02AX02, tolazoline, Thiopental may increase the hypotensive activities of Tolazoline.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Thiopental is combined with Tolperisone.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Thiopental.]
[N06AF04, tranylcypromine, The metabolism of Thiopental can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of adverse effects can be increased when Thiopental is combined with Trazodone.]
[L01XF01, tretinoin, Thiopental may increase the hypotensive activities of Tretinoin.]
[C03DB02, triamterene, Thiopental may increase the hypotensive activities of Triamterene.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Thiopental is combined with Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Trichlormethiazide.]
[A03AB12, mepenzolate, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[S01EB04, demecarium, The therapeutic efficacy of Thiopental can be decreased when used in combination with Demecarium.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Thiopental.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Thiopental is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of adverse effects can be increased when Triflupromazine is combined with Thiopental.]
[N04AA01, trihexyphenidyl, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Alimemazine is combined with Thiopental.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be increased when combined with Thiopental.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Thiopental is combined with Trimethaphan.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Thiopental.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Thiopental.]
[A03BB01, butylscopolamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The risk or severity of adverse effects can be increased when Thiopental is combined with Vilazodone.]
[S01FA06, tropicamide, The risk or severity of adverse effects can be increased when Thiopental is combined with Tropicamide.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Thiopental.]
[C09CA09, azilsartan medoxomil, Thiopental may increase the hypotensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Thiopental is combined with Tubocurarine.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Thiopental.]
[S01AA05, tyrothricin, The therapeutic efficacy of Thiopental can be decreased when used in combination with Tyrothricin.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Thiopental.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Thiopental is combined with Ezogabine.]
[C08DA01, verapamil, Thiopental may increase the hypotensive activities of Verapamil.]
[N06AX09, viloxazine, The risk or severity of adverse effects can be increased when Thiopental is combined with Viloxazine.]
[C04AX07, vincamine, Thiopental may increase the hypotensive activities of Vincamine.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Thiopental.]
[N01AX15, xenon, The therapeutic efficacy of Xenon can be increased when used in combination with Thiopental.]
[C03BA10, xipamide, Thiopental may increase the hypotensive activities of Xipamide.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Thiopental is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Thiopental is combined with Levetiracetam.]
[R03DC01, zafirlukast, The metabolism of Thiopental can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Thiopental can be decreased when combined with Rabeprazole.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Thiopental is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be increased when combined with Thiopental.]
[N02BA01, aspirin, The metabolism of Thiopental can be increased when combined with Acetylsalicylic acid.]
[G04BD07, tolterodine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, Thiopental may increase the hypotensive activities of Atenolol.]
[J02AC03, voriconazole, The serum concentration of Voriconazole can be decreased when it is combined with Thiopental.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Thiopental is combined with Atracurium.]
[S01FA01, atropine, The risk or severity of adverse effects can be increased when Atropine is combined with Thiopental.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Thiopental.]
[J01CA09, azlocillin, The therapeutic efficacy of Thiopental can be decreased when used in combination with Azlocillin.]
[G04BE10, avanafil, The risk or severity of hypotension can be increased when Avanafil is combined with Thiopental.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Thiopental is combined with Lorcaserin.]
[L02BB04, enzalutamide, The serum concentration of Thiopental can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Thiopental.]
[N05CA04, barbital, The metabolism of Thiopental can be increased when combined with Barbital.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Thiopental.]
[C08CA13, lercanidipine, Thiopental may increase the hypotensive activities of Lercanidipine.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Thiopental is combined with Mosapride.]
[N06DA02, donepezil, The therapeutic efficacy of Thiopental can be decreased when used in combination with Donepezil.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Thiopental.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Thiopental.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiopental.]
[R06AC06, thonzylamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AB02, chloroform, The therapeutic efficacy of Chloroform can be increased when used in combination with Thiopental.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Thiopental is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Thiopental can be decreased when combined with Sildenafil.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Thiopental.]
[C04AX11, bencyclane, The metabolism of Bencyclane can be increased when combined with Thiopental.]
[C03AA01, bendroflumethiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Thiopental is combined with Pomalidomide.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Thiopental is combined with Benperidol.]
[A10BK02, canagliflozin, The serum concentration of Canagliflozin can be decreased when it is combined with Thiopental.]
[M04AB03, benzbromarone, The metabolism of Thiopental can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The therapeutic efficacy of Tegaserod can be decreased when used in combination with Thiopental.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Benzocaine.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Thiopental is combined with Naratriptan.]
[N04AC01, benztropine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Thiopental can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Thiopental.]
[C08EA02, bepridil, Thiopental may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, Thiopental may increase the hypotensive activities of Riociguat.]
[C02KX04, macitentan, Thiopental may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Thiopental.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Thiopental is combined with Vortioxetine.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be increased when combined with Thiopental.]
[N03AF04, eslicarbazepine, The metabolism of Thiopental can be decreased when combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Thiopental can be increased when it is combined with Luliconazole.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Thiopental is combined with Vigabatrin.]
[A10BK01, dapagliflozin, Thiopental may increase the hypotensive activities of Dapagliflozin.]
[C07AB04, acebutolol, Thiopental may increase the hypotensive activities of Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Thiopental is combined with Tasimelteon.]
[L04AA32, apremilast, The metabolism of Thiopental can be increased when combined with Apremilast.]
[A16AA06, betaine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Betaine.]
[S03BA03, betamethasone, The metabolism of Thiopental can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Thiopental may increase the hypotensive activities of Betaxolol.]
[C02CC01, bethanidine, Thiopental may increase the hypotensive activities of Bethanidine.]
[L04AC11, siltuximab, The metabolism of Thiopental can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Thiopental.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Thiopental is combined with Alfaxalone.]
[A10BK03, empagliflozin, Thiopental may increase the hypotensive activities of Empagliflozin.]
[D11AA01, glycopyrronium, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Thiopental.]
[J01XA05, oritavancin, The metabolism of Thiopental can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Acepromazine is combined with Thiopental.]
[V04CX03, methacholine, Thiopental may decrease effectiveness of Methacholine as a diagnostic agent.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Thiopental.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Thiopental is combined with Naloxegol.]
[N04AA02, biperiden, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Thiopental.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Thiopental.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be increased when combined with Thiopental.]
[N06AX11, mirtazapine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Thiopental can be increased when combined with Secukinumab.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be increased when combined with Thiopental.]
[A03AA09, difemerine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The metabolism of Tioclomarol can be increased when combined with Thiopental.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Thiopental is combined with Eluxadoline.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Thiopental is combined with Brexpiprazole.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Thiopental is combined with Flibanserin.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Thiopental.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Thiopental is combined with Cariprazine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Thiopental is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Acetophenazine is combined with Thiopental.]
[A02BC03, lansoprazole, The metabolism of Thiopental can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Thiopental.]
[J02AC05, isavuconazole, The metabolism of Thiopental can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Thiopental.]
[B01AC27, selexipag, Thiopental may increase the hypotensive activities of Selexipag.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Thiopental.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Thiopental is combined with Aprobarbital.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Thiopental is combined with Brivaracetam.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Bromazepam.]
[N04BC01, bromocriptine, Thiopental may increase the hypotensive activities of Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Thiopental is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Thiopental.]
[N06AA19, amineptin, The metabolism of Amineptine can be increased when combined with Thiopental.]
[C08CA01, amlodipine, Thiopental may increase the hypotensive activities of Amlodipine.]
[N01AH05, anileridine, The therapeutic efficacy of Anileridine can be increased when used in combination with Thiopental.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Thiopental is combined with Aniracetam.]
[C03CA02, bumetanide, Thiopental may increase the hypotensive activities of Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Bupivacaine.]
[C07AA19, bupranolol, The serum concentration of Bupranolol can be decreased when it is combined with Thiopental.]
[N07BC01, buprenorphine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Thiopental.]
[L01XX27, arsenic trioxide, Thiopental may increase the hypotensive activities of Arsenic trioxide.]
[N06DA03, rivastigmine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Rivastigmine.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Thiopental.]
[M02AA03, clofezone, The metabolism of Thiopental can be decreased when combined with Rabeprazole.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Thiopental is combined with Butorphanol.]
[R06AX09, azatadine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Thiopental can be decreased when combined with Rucaparib.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Thiopental.]
[R03CC12, bambuterol, The therapeutic efficacy of Thiopental can be decreased when used in combination with Bambuterol.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be decreased when it is combined with Thiopental.]
[N07XX16, deutetrabenazine, The risk or severity of sedation and somnolence can be increased when Thiopental is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Thiopental can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Thiopental is combined with Beclamide.]
[N06BC01, caffeine, The serum concentration of Caffeine can be decreased when it is combined with Thiopental.]
[C09AA07, benazepril, Thiopental may increase the hypotensive activities of Benazepril.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Oxybuprocaine.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Thiopental.]
[J05AE09, tipranavir, The metabolism of Thiopental can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Thiopental can be increased when combined with Infliximab.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Thiopental.]
[L01XX59, enasidenib, The metabolism of Thiopental can be decreased when combined with Enasidenib.]
[C07AB07, bisoprolol, Thiopental may increase the hypotensive activities of Bisoprolol.]
[J05AG03, efavirenz, The metabolism of Thiopental can be increased when combined with Efavirenz.]
[C07AA17, bopindolol, The serum concentration of Bopindolol can be decreased when it is combined with Thiopental.]
[N04AA11, bornaprine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[C01DX19, nesiritide, Thiopental may increase the hypotensive activities of Nesiritide.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Thiopental is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Thiopental is combined with Brotizolam.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Thiopental is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Thiopental can be increased when combined with Letermovir.]
[N06AA15, butriptyline, The metabolism of Butriptyline can be increased when combined with Thiopental.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Capsaicin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Thiopental is combined with Vinylbital.]
[C09AA01, captopril, Thiopental may increase the hypotensive activities of Captopril.]
[L02BB05, apalutamide, The serum concentration of Thiopental can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, Carbamazepine may increase the Change in thyroid function activities of Thiopental.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Thiopental.]
[A03AA03, camylofine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Carbinoxamine.]
[C07AG02, carvedilol, Thiopental may increase the hypotensive activities of Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Thiopental.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiopental.]
[C07AB08, celiprolol, The serum concentration of Celiprolol can be decreased when it is combined with Thiopental.]
[N03AX17, stiripentol, The metabolism of Thiopental can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Thiopental can be decreased when combined with Tecovirimat.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Thiopental.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Thiopental is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be decreased when it is combined with Thiopental.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Thiopental.]
[R03BB08, revefenacin, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L04AA39, emapalumab, The metabolism of Thiopental can be increased when combined with Emapalumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Thiopental.]
[C09AA08, cilazapril, Thiopental may increase the hypotensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Thiopental.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Thiopental is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Thiopental can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Esketamine.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Thiopental is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Thiopental is combined with Brexanolone.]
[N05BA09, clobazam, The risk or severity of adverse effects can be increased when Clobazam is combined with Thiopental.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Thiopental.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Thiopental is combined with Cloxazolam.]
[C09CA06, candesartan, Thiopental may increase the hypotensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Thiopental can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The metabolism of Thiopental can be decreased when combined with Alpelisib.]
[J01DD01, cefotaxime, The therapeutic efficacy of Thiopental can be decreased when used in combination with Cefotaxime.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Cyamemazine is combined with Thiopental.]
[C03BX03, cicletanine, Thiopental may increase the hypotensive activities of Cicletanine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Thiopental.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Thiopental.]
[C03AA09, cyclothiazide, Thiopental may increase the hypotensive activities of Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Thiopental is combined with Yohimbine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Thiopental.]
[J01DB03, cephalothin, The therapeutic efficacy of Thiopental can be decreased when used in combination with Cefalotin.]
[G03DB05, demegestone, The metabolism of Demegestone can be increased when combined with Thiopental.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Thiopental.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be increased when combined with Thiopental.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Thiopental.]
[N03AX25, cenobamate, The serum concentration of Thiopental can be increased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Thiopental.]
[R06AB02, dexchlorpheniramine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Dexchlorpheniramine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Thiopental is combined with Dezocine.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Thiopental.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Thiopental.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Thiopental.]
[H02CA02, osilodrostat, The serum concentration of Thiopental can be increased when it is combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Thiopental can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Thiopental is combined with Frovatriptan.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Thiopental is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Thiopental.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Thiopental.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Thiopental is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Thiopental is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Thiopental.]
[C08CA16, clevidipine, The metabolism of Thiopental can be decreased when combined with Clevidipine.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Thiopental is combined with Valpromide.]
[L01AA02, chlorambucil, The therapeutic efficacy of Thiopental can be decreased when used in combination with Chlorambucil.]
[S03AA08, chloramphenicol, The metabolism of Thiopental can be decreased when combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Thiopental.]
[C02AA06, methoserpidine, Thiopental may increase the hypotensive activities of Methoserpidine.]
[A03AA08, dihexyverine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Thiopental.]
[N04BX04, opicapone, Thiopental may increase the hypotensive activities of Opicapone.]
[G04BD09, trospium, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Thiopental.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Thiopental is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Thiopental is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Dyclonine.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Thiopental.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Thiopental.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Thiopental is combined with Remimazolam.]
[N07XX04, sodium oxybate, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AC19, satralizumab, The serum concentration of Thiopental can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Thiopental is combined with Oliceridine.]
[P01BA01, chloroquine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Chloroquine.]
[C03AA04, chlorothiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Chlorothiazide.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Thiopental is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Thiopental.]
[N05AF03, chlorprothixene, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Chlorthalidone.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Thiopental.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Thiopental is combined with Etifoxine.]
[N06BX18, vinpocetine, The metabolism of Vinpocetine can be increased when combined with Thiopental.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Thiopental is combined with Ethyl loflazepate.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be increased when combined with Thiopental.]
[A16AX20, lonafarnib, The metabolism of Thiopental can be decreased when combined with Lonafarnib.]
[C01DX22, vericiguat, Thiopental may increase the hypotensive activities of Vericiguat.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Thiopental is combined with Febarbamate.]
[N03AX10, felbamate, The serum concentration of Thiopental can be increased when it is combined with Felbamate.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be decreased when it is combined with Thiopental.]
[C01CA19, fenoldopam, Thiopental may increase the hypotensive activities of Fenoldopam.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Thiopental.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Thiopental.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Thiopental is combined with Trichloroethylene.]
[H04AA02, dasiglucagon, Thiopental may increase the hypotensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Thiopental can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Thiopental is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be increased when combined with Thiopental.]
[L01XA01, cisplatin, The therapeutic efficacy of Thiopental can be decreased when used in combination with Cisplatin.]
[N06AB04, citalopram, The metabolism of Thiopental can be decreased when combined with Citalopram.]
[H01AC07, somapacitan, The metabolism of Thiopental can be decreased when combined with Somapacitan.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Thiopental.]
[P01CA03, fexinidazole, The metabolism of Thiopental can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The metabolism of Belzutifan can be decreased when combined with Thiopental.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Thiopental.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Thiopental.]
[N06AX25, St. John's wort extract, The metabolism of Thiopental can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Thiopental can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Thiopental.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Thiopental.]
[B06AX04, mitapivat, The metabolism of Thiopental can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Levobupivacaine.]
[N06AA04, clomipramine, The metabolism of Thiopental can be decreased when combined with Clomipramine.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Thiopental.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Thiopental.]
[C01EB24, mavacamten, The serum concentration of Thiopental can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Thiopental can be decreased when combined with Vonoprazan.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Thiopental is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Thiopental is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Thiopental is combined with Granisetron.]
[N05AH02, clozapine, The metabolism of Thiopental can be decreased when combined with Clozapine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Halazepam.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Cocaine.]
[C02KB01, metyrosine, Thiopental may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Thiopental can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Thiopental is combined with Codeine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Thiopental is combined with Hexafluronium.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Thiopental.]
[A03AB10, hexocyclium, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[S01FA05, homatropine, The risk or severity of adverse effects can be increased when Thiopental is combined with Homatropine.]
[A03BB06, homatropine methylbromide, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[N01AB07, desflurane, Thiopental may increase the hypotensive activities of Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Thiopental is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Thiopental is combined with Ifenprodil.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Thiopental is combined with Desloratadine.]
[J05AB14, valganciclovir, The therapeutic efficacy of Thiopental can be decreased when used in combination with Valganciclovir.]
[H01AX01, pegvisomant, The therapeutic efficacy of Thiopental can be decreased when used in combination with Pegvisomant.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Thiopental is combined with Almotriptan.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Thiopental is combined with Ketazolam.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Thiopental.]
[A02BC05, esomeprazole, The metabolism of Thiopental can be decreased when combined with Esomeprazole.]
[C08CA09, lacidipine, Thiopental may increase the hypotensive activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Thiopental.]
[N03AX09, lamotrigine, The serum concentration of Lamotrigine can be decreased when it is combined with Thiopental.]
[N07BC04, lofexidine, The therapeutic efficacy of Thiopental can be increased when used in combination with Lofexidine.]
[R06AX13, loratadine, Thiopental may increase the anticholinergic activities of Loratadine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Lormetazepam.]
[H01AA02, cosyntropin, The risk or severity of liver damage can be increased when Tetracosactide is combined with Thiopental.]
[C09AA03, lisinopril, Thiopental may increase the hypotensive activities of Lisinopril.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Thiopental.]
[C08CA11, manidipine, The metabolism of Thiopental can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Medifoxamine.]
[C07AA14, mepindolol, The serum concentration of Mepindolol can be decreased when it is combined with Thiopental.]
[R06AD04, methdilazine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, The metabolism of Cyclandelate can be increased when combined with Thiopental.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Thiopental is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Thiopental is combined with Cyclobarbital.]
[C03DA04, eplerenone, Thiopental may increase the hypotensive activities of Eplerenone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Thiopental is combined with Melperone.]
[C03AA07, cyclopenthiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Cyclopenthiazide.]
[S01FA04, cyclopentolate, The risk or severity of adverse effects can be increased when Thiopental is combined with Cyclopentolate.]
[L01AA01, cyclophosphamide, The metabolism of Thiopental can be decreased when combined with Cyclophosphamide.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Thiopental.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be increased when combined with Thiopental.]
[N06AG02, moclobemide, The metabolism of Thiopental can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Thiopental can be decreased when combined with Modafinil.]
[R06AX02, cyproheptadine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C09AA13, moexipril, Thiopental may increase the hypotensive activities of Moexipril.]
[C03XA02, conivaptan, Thiopental may increase the hypotensive activities of Conivaptan.]
[C02AC05, moxonidine, Thiopental may increase the hypotensive activities of Moxonidine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Thiopental.]
[M01AH05, etoricoxib, The metabolism of Thiopental can be decreased when combined with Etoricoxib.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Thiopental is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Thiopental is combined with Deanol.]
[C02CC04, debrisoquin, Thiopental may increase the hypotensive activities of Debrisoquine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Nordazepam.]
[C07AB12, nebivolol, Thiopental may increase the hypotensive activities of Nebivolol.]
[N06AX06, nefazodone, The risk or severity of adverse effects can be increased when Thiopental is combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Thiopental is combined with Niaprazine.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Thiopental.]
[L02BB02, nilutamide, The metabolism of Thiopental can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Thiopental is combined with Tiagabine.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be increased when combined with Thiopental.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be decreased when it is combined with Thiopental.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Thiopental.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Thiopental is combined with Normethadone.]
[N06AB10, escitalopram, The risk or severity of adverse effects can be increased when Thiopental is combined with Escitalopram.]
[G04BD08, solifenacin, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[N06AA01, desipramine, The metabolism of Desipramine can be increased when combined with Thiopental.]
[C09XA02, aliskiren, Thiopental may increase the hypotensive activities of Aliskiren.]
[N03AF02, oxcarbazepine, The metabolism of Thiopental can be decreased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Thiopental can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Thiopental is combined with Oxiracetam.]
[N04AA08, dexetimide, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Thiopental can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Thiopental.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Thiopental is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Thiopental is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of adverse effects can be increased when Thiopental is combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Thiopental.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Thiopental is combined with Diamorphine.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be decreased when it is combined with Thiopental.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Thiopental is combined with Phenacemide.]
[V03AH01, diazoxide, Thiopental may increase the hypotensive activities of Diazoxide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Phenol.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Thiopental is combined with Phensuximide.]
[N06AA08, dibenzepin, The metabolism of Dibenzepin can be increased when combined with Thiopental.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Cinchocaine.]
[S01EC02, dichlorphenamide, Thiopental may increase the hypotensive activities of Diclofenamide.]
[A03AA07, dicyclomine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, Thiopental may increase the hypotensive activities of Pinacidil.]
[A03AX04, pinaverium, The metabolism of Pinaverium can be increased when combined with Thiopental.]
[N05AD05, pipamperone, Thiopental may increase the hypotensive activities of Pipamperone.]
[A03AB14, pipenzolate, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Thiopental.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Diethylcarbamazine.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Thiopental is combined with Diethylpropion.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be increased when combined with Thiopental.]
[C08CA03, isradipine, Thiopental may increase the hypotensive activities of Isradipine.]
[A03AB11, poldine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[C02DB01, dihydralazine, Thiopental may increase the hypotensive activities of Dihydralazine.]
[N02CA01, dihydroergotamine, The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Thiopental.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Thiopental is combined with Hydromorphone.]
[B01AC21, treprostinil, Thiopental may increase the hypotensive activities of Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Pramocaine.]
[C08DB01, diltiazem, Thiopental may increase the hypotensive activities of Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Thiopental is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Thiopental is combined with Pridinol.]
[R06AB03, dimethindene, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Thiopental can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Thiopental is combined with Progabide.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be decreased when it is combined with Thiopental.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Proparacaine.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be decreased when it is combined with Thiopental.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Thiopental is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Quazepam.]
[C09AA06, quinapril, Thiopental may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, Thiopental may increase the hypotensive activities of Dipyridamole.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Thiopental is combined with Dexmethylphenidate.]
[N06AA23, quinupramine, The metabolism of Quinupramine can be increased when combined with Thiopental.]
[A03FA02, cisapride, The risk or severity of adverse effects can be increased when Thiopental is combined with Cisapride.]
[C09AA05, ramipril, Thiopental may increase the hypotensive activities of Ramipril.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Thiopental.]
[C01BA03, disopyramide, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[N07AA03, distigmine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Distigmine.]
[P03AA04, disulfiram, The therapeutic efficacy of Thiopental can be decreased when used in combination with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Thiopental can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Thiopental can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Thiopental is combined with Riluzole.]
[N05AX08, risperidone, Thiopental may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Thiopental is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Ropivacaine.]
[L01XG01, bortezomib, The metabolism of Thiopental can be decreased when combined with Bortezomib.]
[G04BE08, tadalafil, Thiopental may increase the hypotensive activities of Tadalafil.]
[C02KX02, ambrisentan, Thiopental may increase the hypotensive activities of Ambrisentan.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Thiopental.]
[N06AA16, dothiepin, The metabolism of Thiopental can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be increased when combined with Thiopental.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Thiopental.]
[J01AA02, doxycycline, The serum concentration of Doxycycline can be decreased when it is combined with Thiopental.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[N06AB06, sertraline, The metabolism of Thiopental can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, Thiopental may increase the hypotensive activities of Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Thiopental is combined with Sibutramine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Thiopental can be decreased when used in combination with Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Thiopental.]
[C09AA11, spirapril, Thiopental may increase the hypotensive activities of Spirapril.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be decreased when it is combined with Thiopental.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Thiopental is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Thiopental is combined with Sumatriptan.]
[V04CX07, edrophonium, The therapeutic efficacy of Thiopental can be decreased when used in combination with Edrophonium.]
[C07AB13, talinolol, The serum concentration of Talinolol can be decreased when it is combined with Thiopental.]
[G04CA03, terazosin, Thiopental may increase the hypotensive activities of Terazosin.]
[G04BD05, terodiline, The metabolism of Terodiline can be increased when combined with Thiopental.]
[C07AA16, tertatolol, The serum concentration of Tertatolol can be decreased when it is combined with Thiopental.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Thiopental resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Thiopental is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Thiopental is combined with Thiopropazate.]
[G04BD01, emepronium, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Thiopental.]
[C09AA02, enalapril, Thiopental may increase the hypotensive activities of Enalapril.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Thiopental is combined with Tofisopam.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Thiopental.]
[N03AX11, topiramate, The metabolism of Thiopental can be decreased when combined with Topiramate.]
[C03CA04, torsemide, Thiopental may increase the hypotensive activities of Torasemide.]
[C09AA10, trandolapril, Thiopental may increase the hypotensive activities of Trandolapril.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Thiopental is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Thiopental is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Thiopental is combined with Triclofos.]
[A03AB08, tridihexethyl, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Thiopental is combined with Trimethobenzamide.]
[N04AA12, tropatepine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Thiopental.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Thiopental is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Thiopental is combined with Veralipride.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Thiopental is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiopental.]
[S01GA03, xylometazoline, The metabolism of Xylometazoline can be increased when combined with Thiopental.]
[C08CA12, mepirodipine, Thiopental may increase the hypotensive activities of Barnidipine.]
[C09AA15, zofenopril, Thiopental may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The metabolism of Thiopental can be decreased when combined with Zonisamide.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Thiopental.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Thiopental is combined with Zotepine.]
[C02AC02, guanfacine, Thiopental may increase the hypotensive activities of Guanfacine.]
[B01AC11, iloprost, Thiopental may increase the hypotensive activities of Iloprost.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Moricizine is combined with Thiopental.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Thiopental is combined with Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Thiopental is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Ergotamine.]
[N03AG01, valproic acid, The serum concentration of Thiopental can be increased when it is combined with Valproic acid.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Thiopental is combined with Estazolam.]
[A02BC02, pantoprazole, The metabolism of Thiopental can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The metabolism of Estradiol can be increased when combined with Thiopental.]
[J04AK02, ethambutol, The metabolism of Thiopental can be decreased when combined with Ethambutol.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Thiopental.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be increased when combined with Thiopental.]
[V03AF05, amifostine, Thiopental may increase the hypotensive activities of Amifostine.]
[N04AA05, profenamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The metabolism of Ethosuximide can be increased when combined with Thiopental.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Thiopental is combined with Ethotoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Thiopental is combined with Ethylmorphine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Etidocaine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Thiopental.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Thiopental is combined with Sertindole.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Thiopental.]
[A02BA04, nizatidine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Nizatidine.]
[R06AX12, terfenadine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Thiopental is combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Thiopental can be decreased when combined with Fluvoxamine.]
[P02CA03, albendazole, The metabolism of Thiopental can be decreased when combined with Albendazole.]
[C08CA02, felodipine, Thiopental may increase the hypotensive activities of Felodipine.]
[C08EA01, fendiline, The metabolism of Fendiline can be increased when combined with Thiopental.]
[N03AX26, fenfluramine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thiopental.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Thiopental is combined with Fenoterol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Thiopental.]
[L01BB06, clofarabine, Thiopental may increase the hypotensive activities of Clofarabine.]
[G04BD02, flavoxate, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[J02AC01, fluconazole, The metabolism of Thiopental can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be increased when combined with Thiopental.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Flunitrazepam.]
[N06AA14, melitracen, The metabolism of Melitracen can be increased when combined with Thiopental.]
[V03AZ01, ethanol, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[N06AB03, fluoxetine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Flupentixol may increase the sedative activities of Thiopental.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiopental.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Flurazepam.]
[N05AG01, fluspirilene, The metabolism of Fluspirilene can be increased when combined with Thiopental.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Thiopental is combined with Alcuronium.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Thiopental.]
[C03CA01, furosemide, Thiopental may increase the hypotensive activities of Furosemide.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Thiopental is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Thiopental is combined with Amisulpride.]
[N06DA04, galantamine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Galantamine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Gallamine.]
[C08DA02, gallopamil, The metabolism of Gallopamil can be increased when combined with Thiopental.]
[S01AD09, ganciclovir, The therapeutic efficacy of Thiopental can be decreased when used in combination with Ganciclovir.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Thiopental.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Thiopental is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Thiopental can be decreased when combined with Gemfibrozil.]
[N04BC06, cabergoline, The risk or severity of adverse effects can be increased when Cabergoline is combined with Thiopental.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be decreased when it is combined with Thiopental.]
[J05AG04, etravirine, The metabolism of Thiopental can be decreased when combined with Etravirine.]
[N03AD03, methsuximide, The metabolism of Thiopental can be decreased when combined with Methsuximide.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be increased when combined with Thiopental.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Thiopental is combined with Alfentanil.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Thiopental.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Thiopental.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Thiopental.]
[N05CM18, dexmedetomidine, Thiopental may increase the hypotensive activities of Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Thiopental is combined with Glutethimide.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Thiopental.]
[C05AE01, nitroglycerin, Thiopental may increase the hypotensive activities of Nitroglycerin.]
[C02CA04, doxazosin, Thiopental may increase the hypotensive activities of Doxazosin.]
[C07AB09, esmolol, Thiopental may increase the hypotensive activities of Esmolol.]
[B01AA12, fluindione, The metabolism of Fluindione can be increased when combined with Thiopental.]
[C09AA09, fosinopril, Thiopental may increase the hypotensive activities of Fosinopril.]
[D01BA01, griseofulvin, The serum concentration of Griseofulvin can be decreased when it is combined with Thiopental.]
[S01EX01, guanethidine, Thiopental may increase the hypotensive activities of Guanethidine.]
[P01BX01, halofantrine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Thiopental.]
[N01AB01, halothane, Thiopental may increase the hypotensive activities of Halothane.]
[N05AH04, quetiapine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Thiopental is combined with Iprazochrome.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Thiopental is combined with Allobarbital.]
[C09CA01, losartan, The metabolism of Thiopental can be decreased when combined with Losartan.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Thiopental.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Thiopental.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Thiopental.]
[C08CA10, nilvadipine, The metabolism of Thiopental can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The metabolism of Nimesulide can be increased when combined with Thiopental.]
[C09AA04, perindopril, Thiopental may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, Thiopental may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Thiopental can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Hydroflumethiazide.]
[G04BD06, propiverine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Thiopental is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[J04AB04, rifabutin, The metabolism of Thiopental can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, Thiopental may increase the hypotensive activities of Rilmenidine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Thiopental.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Thiopental.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Thiopental is combined with Sufentanil.]
[N06AA02, imipramine, The metabolism of Thiopental can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, Thiopental may increase the hypotensive activities of Paclitaxel.]
[M03BX02, tizanidine, Thiopental may increase the hypotensive activities of Tizanidine.]
[L01CE01, topotecan, Thiopental may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Indapamide.]
[C02CA02, indoramin, Thiopental may increase the hypotensive activities of Indoramin.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Thiopental.]
[A03AA30, piperidolate, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Articaine.]
[V08AB02, iohexol, The therapeutic efficacy of Thiopental can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Thiopental.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Thiopental is combined with Ramelteon.]
[R06AE01, buclizine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C07AA01, alprenolol, The serum concentration of Alprenolol can be decreased when it is combined with Thiopental.]
[C03BA02, quinethazone, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Quinethazone.]
[N06AA13, iprindole, The metabolism of Iprindole can be increased when combined with Thiopental.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Thiopental.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Chlorproethazine is combined with Thiopental.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Thiopental.]
[C09AA16, imidapril, Thiopental may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, Thiopental may increase the hypotensive activities of Isoflurane.]
[S01EB07, isoflurophate, The therapeutic efficacy of Thiopental can be decreased when used in combination with Isoflurophate.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Thiopental.]
[J04AC01, isoniazid, The metabolism of Thiopental can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, The therapeutic efficacy of Thiopental can be decreased when used in combination with Isoprenaline.]
[C01DA14, isosorbide mononitrate, Thiopental may increase the hypotensive activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Thiopental may increase the hypotensive activities of Isosorbide dinitrate.]
[C04AA01, isoxsuprine, Thiopental may increase the hypotensive activities of Isoxsuprine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Thiopental.]
[L04AC07, tocilizumab, The metabolism of Thiopental can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Thiopental is combined with Ketanserin.]
[N05AH03, olanzapine, The metabolism of Thiopental can be decreased when combined with Olanzapine.]
[L04AA24, abatacept, The metabolism of Thiopental can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Thiopental may increase the sedative activities of Rotigotine.]
[J01MB02, nalidixic acid, The therapeutic efficacy of Thiopental can be decreased when used in combination with Nalidixic acid.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Thiopental can be decreased when used in combination with Gamolenic acid.]
[C07AG01, labetalol, Thiopental may increase the hypotensive activities of Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Thiopental is combined with Amantadine.]
[C02AA05, deserpidine, Thiopental may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Thiopental.]
[N07AA30, ambenonium, The therapeutic efficacy of Thiopental can be decreased when used in combination with Ambenonium.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Thiopental.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Thiopental is combined with Lacosamide.]
[C03CC01, ethacrynic acid, Thiopental may increase the hypotensive activities of Etacrynic acid.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be increased when combined with Thiopental.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Lidocaine.]
[C08EX01, lidoflazine, The metabolism of Lidoflazine can be increased when combined with Thiopental.]
[N06BA13, armodafinil, The metabolism of Thiopental can be decreased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Thiopental.]
[C03DB01, amiloride, Thiopental may increase the hypotensive activities of Amiloride.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Lisuride is combined with Thiopental.]
[N06AA07, lofepramine, The metabolism of Lofepramine can be increased when combined with Thiopental.]
[A07DA03, loperamide, The metabolism of Loperamide can be increased when combined with Thiopental.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Thiopental.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Thiopental.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Thiopental.]
[J01AA04, lymecycline, The metabolism of Lymecycline can be increased when combined with Thiopental.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be increased when combined with Thiopental.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Thiopental.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Thiopental.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Thiopental can be increased when used in combination with Magnesium sulfate.]
[V04CX04, mannitol, Thiopental may increase the hypotensive activities of Mannitol.]
[N06AA21, maprotiline, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Thiopental.]
[C02BB01, mecamylamine, Thiopental may increase the hypotensive activities of Mecamylamine.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Mechlorethamine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Thiopental is combined with Meclizine.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Medazepam.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Thiopental.]
[G03DB03, medrogestone, The serum concentration of Medrogestone can be decreased when it is combined with Thiopental.]
[P01BC02, mefloquine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Mefloquine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Thiopental is combined with Melatonin.]
[N06DX01, memantine, The metabolism of Thiopental can be decreased when combined with Memantine.]
[N02AB02, meperidine, Thiopental may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Meperidine.]
[N03AB04, mephenytoin, The metabolism of Thiopental can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Thiopental.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Thiopental.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Thiopental is combined with Meptazinol.]
[L02BG01, aminoglutethimide, The metabolism of Thiopental can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiopental.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Thiopental is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Thiopental is combined with Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Thiopental.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Metamfetamine.]
[A03AB07, methantheline, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Thiopental is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Thiopental is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Thiopental.]
[S01EC05, methazolamide, Thiopental may increase the hypotensive activities of Methazolamide.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Thiopental is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Thiopental can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Thiopental.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Thiopental.]
[A11HA02, pyridoxine, The metabolism of Thiopental can be increased when combined with Pyridoxine.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Thiopental is combined with Ziconotide.]
[N05AA02, methotrimeprazine, The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Thiopental.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Thiopental is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Methyclothiazide.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Thiopental.]
[C02AB01, methyldopa, Thiopental may increase the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, The risk or severity of adverse effects can be increased when Methylene blue is combined with Thiopental.]
[R03DA05, aminophylline, The therapeutic efficacy of Thiopental can be decreased when used in combination with Aminophylline.]
[N06BA04, methylphenidate, The therapeutic efficacy of Thiopental can be decreased when used in combination with Methylphenidate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Thiopental.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Thiopental is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Thiopental.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Thiopental.]
[C03BA08, metolazone, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Metolazone.]
[C07AB02, metoprolol, Thiopental may increase the hypotensive activities of Metoprolol.]
[P01AB01, metronidazole, The therapeutic efficacy of Thiopental can be decreased when used in combination with Metronidazole.]
[N06AX03, mianserin, The therapeutic efficacy of Thiopental can be decreased when used in combination with Mianserin.]
[S02AA13, miconazole, The metabolism of Thiopental can be decreased when combined with Miconazole.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Thiopental.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be increased when combined with Thiopental.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Thiopental.]
[C09CA03, valsartan, Thiopental may increase the hypotensive activities of Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[D11AX01, minoxidil, Thiopental may increase the hypotensive activities of Minoxidil.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Thiopental is combined with Molindone.]
[L03AC01, aldesleukin, Thiopental may increase the hypotensive activities of Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Thiopental can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Thiopental can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Thiopental is combined with Morphine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Thiopental.]
[L04AB05, certolizumab pegol, The metabolism of Thiopental can be increased when combined with Certolizumab pegol.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Thiopental is combined with Vecuronium.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Thiopental.]
[R03BB01, ipratropium bromide, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be increased when combined with Thiopental.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Thiopental.]
[C07AA12, nadolol, Thiopental may increase the hypotensive activities of Nadolol.]
[N04BC04, ropinirole, Thiopental may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Thiopental is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Thiopental is combined with Nalbuphine.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Thiopental is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Thiopental can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of CNS depression can be increased when Naphazoline is combined with Thiopental.]
[N06BA01, amphetamine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Amphetamine.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Thiopental is combined with Duloxetine.]
[N04BX01, tolcapone, Thiopental may increase the hypotensive activities of Tolcapone.]
[L02BG04, letrozole, The metabolism of Thiopental can be decreased when combined with Letrozole.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Thiopental is combined with Remifentanil.]
[C01CX08, levosimendan, Thiopental may increase the hypotensive activities of Levosimendan.]
[S01EB06, neostigmine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Neostigmine.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Thiopental.]
[J02AA01, amphotericin B, Thiopental may increase the hypotensive activities of Amphotericin B.]
[N06AX23, desvenlafaxine, The risk or severity of adverse effects can be increased when Thiopental is combined with Desvenlafaxine.]
[C09CA07, telmisartan, The metabolism of Thiopental can be decreased when combined with Telmisartan.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Thiopental.]
[C08CA04, nicardipine, The metabolism of Thiopental can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Thiopental may increase the hypotensive activities of Nifedipine.]
[V03AB22, amyl nitrite, Thiopental may increase the hypotensive activities of Amyl Nitrite.]
[C08CA06, nimodipine, Thiopental may increase the hypotensive activities of Nimodipine.]
[C08CA07, nisoldipine, Thiopental may increase the hypotensive activities of Nisoldipine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Nitrazepam.]
[C08CA08, nitrendipine, Thiopental may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, Thiopental may increase the hypotensive activities of Nitric Oxide.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Thiopental is combined with Zaleplon.]
[N04BC05, pramipexole, Thiopental may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Thiopental may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Thiopental is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Thiopental is combined with Nomifensine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be increased when combined with Thiopental.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Thiopental.]
[C02KX01, bosentan, Thiopental may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Thiopental.]
[G02CA02, nylidrin, The metabolism of Nylidrin can be increased when combined with Thiopental.]
[L04AC04, rilonacept, The metabolism of Thiopental can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Thiopental can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The metabolism of Opipramol can be increased when combined with Thiopental.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Thiopental is combined with Opium.]
[G04CA02, tamsulosin, Thiopental may increase the hypotensive activities of Tamsulosin.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Oxazepam.]
[C07AA02, oxprenolol, Thiopental may increase the hypotensive activities of Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Thiopental is combined with Oxycodone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Thiopental is combined with Oxymorphone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Thiopental is combined with Oxypertine.]
[A03AB03, oxyphenonium, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Thiopental is combined with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[M03AC01, pancuronium, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be increased when combined with Thiopental.]
[G04BE02, papaverine, Thiopental may increase the hypotensive activities of Papaverine.]
[N05CC05, paraldehyde, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Thiopental.]
[G04BD11, fesoterodine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Thiopental may increase the hypotensive activities of Penbutolol.]
[N05AG03, penfluridol, The metabolism of Penfluridol can be increased when combined with Thiopental.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Thiopental is combined with Pentazocine.]
[N05CA01, pentobarbital, Pentobarbital may increase the hypotensive activities of Thiopental.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be decreased when it is combined with Thiopental.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Perazine is combined with Thiopental.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Thiopental is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be increased when combined with Thiopental.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Perphenazine is combined with Thiopental.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Thiopental is combined with Phenazocine.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Thiopental.]
[B01AA02, phenindione, The metabolism of Phenindione can be increased when combined with Thiopental.]
[N03AA02, phenobarbital, The metabolism of Thiopental can be increased when combined with Phenobarbital.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Thiopental.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Thiopental is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, Thiopental may increase the hypotensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be increased when combined with Thiopental.]
[V03AB36, phentolamine, Thiopental may increase the hypotensive activities of Phentolamine.]
[A02BC06, dexlansoprazole, The metabolism of Thiopental can be decreased when combined with Dexlansoprazole.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Phenylpropanolamine.]
[N03AB02, phenytoin, The metabolism of Thiopental can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Thiopental can be increased when combined with Golimumab.]
[V03AB19, physostigmine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Physostigmine.]
[C08CX01, mibefradil, The metabolism of Mibefradil can be increased when combined with Thiopental.]
[N05AG02, pimozide, The risk or severity of adverse effects can be increased when Thiopental is combined with Pimozide.]
[C07AA03, pindolol, Thiopental may increase the hypotensive activities of Pindolol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Thiopental.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Pipotiazine is combined with Thiopental.]
[C09CA02, eprosartan, Thiopental may increase the hypotensive activities of Eprosartan.]
[A02BX03, pirenzepine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Thiopental is combined with Piritramide.]
[N02CX01, pizotyline, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Thiopental can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, Thiopental may increase the hypotensive activities of Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Thiopental is combined with Proxibarbal.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Thiopental.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Thiopental is combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Thiopental can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of hypotension and orthostatic hypotension can be increased when Thiopental is combined with Polythiazide.]
[J05AE03, ritonavir, The metabolism of Thiopental can be decreased when combined with Ritonavir.]
[C07AB01, practolol, The serum concentration of Practolol can be decreased when it is combined with Thiopental.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Thiopental is combined with Prazepam.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Thiopental.]
[C02CA01, prazosin, Thiopental may increase the hypotensive activities of Prazosin.]
[C01DX02, prenylamine, The metabolism of Prenylamine can be increased when combined with Thiopental.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Prilocaine.]
[N03AA03, primidone, The metabolism of Thiopental can be increased when combined with Primidone.]
[C01BA02, procainamide, The therapeutic efficacy of Thiopental can be decreased when used in combination with Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Procaine.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Thiopental.]
[C10AB05, fenofibrate, The metabolism of Thiopental can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Thiopental.]
[N04AA04, procyclidine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be increased when combined with Thiopental.]
[N05AA03, promazine, The risk or severity of adverse effects can be increased when Promazine is combined with Thiopental.]
[R06AD02, promethazine, The risk or severity of adverse effects can be increased when Promethazine is combined with Thiopental.]
[C01BC03, propafenone, The serum concentration of Propafenone can be decreased when it is combined with Thiopental.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Thiopental is combined with Propanidid.]
[A03AB05, propantheline, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Periciazine is combined with Thiopental.]
[N05CM06, propiomazine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[N01AX10, propofol, Thiopental may increase the hypotensive activities of Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Thiopental is combined with Dextropropoxyphene.]
[C07AA05, propranolol, Thiopental may increase the hypotensive activities of Propranolol.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Thiopental is combined with Rizatriptan.]
[B01AC09, epoprostenol, Thiopental may increase the hypotensive activities of Epoprostenol.]
[N06AA11, protriptyline, The metabolism of Protriptyline can be increased when combined with Thiopental.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Thiopental.]
[A03AB15, diphemanil, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Thiopental.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Thiopental is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Thiopental is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Thiopental is combined with Pyrantel.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Thiopental can be decreased when used in combination with Pyridostigmine.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Thiopental is combined with Mepyramine.]
[C01BA01, quinidine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[P01BC01, quinine, The metabolism of Thiopental can be decreased when combined with Quinine.]
[C02AA01, rescinnamine, Thiopental may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, Thiopental may increase the hypotensive activities of Reserpine.]
[J04AB02, rifampin, The metabolism of Thiopental can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Thiopental is combined with Oxitriptan.]
[S01FA02, scopolamine, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The metabolism of Thiopental can be increased when combined with Secobarbital.]
[V04CK01, secretin, The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Thiopental.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Thiopental.]
[L01FA03, obinutuzumab, Thiopental may increase the hypotensive activities of Obinutuzumab.]
[H01CB01, somatostatin, The risk or severity of adverse effects can be increased when Somatostatin is combined with Thiopental.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Thiopental.]
[C07AA07, sotalol, Thiopental may increase the hypotensive activities of Sotalol.]
[C03DA01, spironolactone, Thiopental may increase the hypotensive activities of Spironolactone.]
